Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Gains from Investment Securities (2022 - 2025)

Prokidney (PROK) has disclosed Gains from Investment Securities for 4 consecutive years, with -$10000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities rose 99.61% to -$10000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 million, a 1764.6% increase, with the full-year FY2024 number at $19.8 million, up 34.73% from a year prior.
  • Gains from Investment Securities was -$10000.0 for Q3 2025 at Prokidney, up from -$786000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $15.7 million in Q2 2023 to a low of -$2.6 million in Q3 2024.
  • A 4-year average of $1.2 million and a median of $159500.0 in 2022 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 4014.9% in 2023; the steepest drop was 398.78% in 2023.
  • Prokidney's Gains from Investment Securities stood at -$1.1 million in 2022, then soared by 106.49% to $73000.0 in 2023, then soared by 3435.62% to $2.6 million in 2024, then plummeted by 100.39% to -$10000.0 in 2025.
  • Per Business Quant, the three most recent readings for PROK's Gains from Investment Securities are -$10000.0 (Q3 2025), -$786000.0 (Q2 2025), and $322000.0 (Q1 2025).